DD Stock Recent News

The 16,000-square-foot expansion enhances DuPont's global sterile operations, increases the capacity of the manufacturing site's existing medical tubing operations, and enables Costa Rica's first-ever production of sterile healthcare packaging. WILMINGTON, Del.

TOKYO , June 3, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced its participation in the Total Solution Exhibition for Electronic Equipment 2025 (JPCA Show 2025), taking place from June 4-6 at the Tokyo Big Sight East Exhibition Halls. At Booth #6C-03, DuPont will showcase its extensive portfolio of advanced interconnect solutions, which encompass fine line, signal integrity, power and thermal management.

Innovation, cost savings and healthcare acquisitions support DD as it navigates weak demand and hefty separation costs in 2025.

Dow tackles weak demand with cost cuts and cash actions, while DuPont gains from acquisitions in healthcare and innovation.

DD hits 100% renewable electricity for EU operations, marking a major step toward its 2050 net-zero emissions goal using RECs and solar installations.

Company marks significant progress towards 2050 climate goals WILMINGTON, Del. , May 27, 2025 /PRNewswire/ -- DuPont (NYSE: DD) today announced 100 percent of its grid electricity is from renewable sources across its entire European Union (EU) operations, through the use of Renewable Energy Certificates (RECs).

DD launches AmberChrom TQ1 resin, boosting oligonucleotide and peptide purification with high capacity, purity, and scalability.

Agarose-based chromatography resin supports purification of oligonucleotides and peptides for biopharma applications  WILMINGTON, Del. , May 22, 2025 /PRNewswire/ -- DuPont has expanded its bioprocessing portfolio with the launch of DuPont™ AmberChrom™ TQ1 chromatography resin for the purification of oligonucleotides and peptides in support of a wide-range of biopharma applications.

The market has recovered most of its losses from last month's correction, and many quality stocks appear expensive again, prompting some investors to wait for another correction. DuPont de Nemours, Inc. offers 27% upside potential, a safe 2%+ yield, and strong fundamentals, with growth expected as macro conditions improve and a segment spin-off ahead. PepsiCo, Inc. faces near-term headwinds and slow growth, but its 4% yield, robust balance sheet, and transition to healthier products offer long-term upside.

CAMBRIDGE, Mass. and WILMINGTON, Del.